Skip to main content
Top
Published in: Rheumatology International 1/2009

01-11-2009 | Original Article

DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren syndrome and healthy subjects

Authors: Salima Belguith-Maalej, Hassen Hadj-Kacem, Neila Kaddour, Zouhir Bahloul, Hammadi Ayadi

Published in: Rheumatology International | Issue 1/2009

Login to get access

Abstract

Autoimmune diseases (AID) are caused by the loss of immunological tolerance against self-antigens. The deoxyribonuclease I (DNASE1) gene seems to participate in the genetic susceptibility of some AID. In fact, two mutations were reported among systemic lupus erythematosus (SLE) patients from Japan and Spain (the 172 A → T mutation (K5X) and the 46_72 deletion, respectively). The aim of our work was to evaluate the DNASE1 contribution in the genetic susceptibility of rheumatoid arthritis (RA, n = 151), Sjögren syndrome (SS, n = 55) and SLE (n = 34) in Tunisia. DNA from patients and healthy subjects (n = 232) were explored. Both reported mutations were absent among patient and control subjects. The DNASE1 exon2 sequence was analysed among 26 control subjects to identify new polymorphic variations that are possible. Five known SNPs were explored. The G/T transversion (rs8176927: R2S) was the most polymorphic functional nonsynonymous SNP. Using PCR-RFLP method, all DNAs were genotyped for rs8176927 for a case–control design. The statistical analysis showed no significant differences between patients and controls genotype data. In conclusion, our study showed, on the one hand, the absence of the K5X mutation and the 46_72 deletion in Tunisian patients affected with RA, SS and SLE and healthy subjects, and, on the other hand, the absence of association between the R2S polymorphism and the genetic susceptibility of RA, SS and SLE.
Literature
1.
go back to reference Yasuda T, Awazu S, Sato W et al (1990) Human genetically polymorphic deoxyribonuclease: purification, characterization, and multiplicity of urine deoxyribonuclease I. J Biochem 108:393–398PubMed Yasuda T, Awazu S, Sato W et al (1990) Human genetically polymorphic deoxyribonuclease: purification, characterization, and multiplicity of urine deoxyribonuclease I. J Biochem 108:393–398PubMed
2.
go back to reference Rauch F, Polzar B, Stephan H et al (1997) Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptic elimination. J Cell Biol 137:909–923. doi:10.1083/jcb.137.4.909 CrossRefPubMed Rauch F, Polzar B, Stephan H et al (1997) Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptic elimination. J Cell Biol 137:909–923. doi:10.​1083/​jcb.​137.​4.​909 CrossRefPubMed
3.
go back to reference Mannherz HG, Peitsch MC, Zanotti S et al (1995) A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 198:161–174PubMed Mannherz HG, Peitsch MC, Zanotti S et al (1995) A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 198:161–174PubMed
11.
go back to reference Ter Borg EJ, Horst G, Hummel EJ et al (1990) Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term prospective study. Arthritis Rheum 33:634–643. doi:10.1002/art.1780330505 CrossRefPubMed Ter Borg EJ, Horst G, Hummel EJ et al (1990) Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term prospective study. Arthritis Rheum 33:634–643. doi:10.​1002/​art.​1780330505 CrossRefPubMed
17.
go back to reference Simmonds MJ, Heward JM, Kelly MA et al (2002) A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves’ disease: comment on the article by Rood et al. Arthritis Rheum 46:3109–3110. doi:10.1002/art.10414 CrossRefPubMed Simmonds MJ, Heward JM, Kelly MA et al (2002) A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves’ disease: comment on the article by Rood et al. Arthritis Rheum 46:3109–3110. doi:10.​1002/​art.​10414 CrossRefPubMed
18.
go back to reference Chakraborty P, Hadj Kacem H, Makni-Karray K et al (2003) The A/T mutation in exon 2 of the DNASE1 gene is not present in Tunisian patients with systemic lupus erythematosus or in healthy subjects. Arthritis Rheum 48:3297–3298. doi:10.1002/art.11318 CrossRefPubMed Chakraborty P, Hadj Kacem H, Makni-Karray K et al (2003) The A/T mutation in exon 2 of the DNASE1 gene is not present in Tunisian patients with systemic lupus erythematosus or in healthy subjects. Arthritis Rheum 48:3297–3298. doi:10.​1002/​art.​11318 CrossRefPubMed
20.
go back to reference Balada E, Ordi-Ros J, Hernanz S et al (2002) DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum 46:1974–1976. doi:10.1002/art.10349 CrossRefPubMed Balada E, Ordi-Ros J, Hernanz S et al (2002) DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum 46:1974–1976. doi:10.​1002/​art.​10349 CrossRefPubMed
23.
go back to reference Kaplan G (1991) Syndrome de Gougerot-Sjögren. In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds) Les maladies systémique, 2nd edn. Flammarion Médecine-Sciences, Paris, pp 499–544 Kaplan G (1991) Syndrome de Gougerot-Sjögren. In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds) Les maladies systémique, 2nd edn. Flammarion Médecine-Sciences, Paris, pp 499–544
25.
go back to reference Kawazaki E (1990) Sample preparation from blood, cells and other fluids. In: Innis M, Gelffand D, Snisky G, White T (eds) PCR protocols. A guide to methods and application, 2nd edn. Academic Press, San Diego, pp 146–152 Kawazaki E (1990) Sample preparation from blood, cells and other fluids. In: Innis M, Gelffand D, Snisky G, White T (eds) PCR protocols. A guide to methods and application, 2nd edn. Academic Press, San Diego, pp 146–152
29.
go back to reference Benucci M, Saviola G, Baiardi P et al (2008) Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis. Clin Rheumatol 27:91–95. doi:10.1007/s10067-007-0728-5 CrossRefPubMed Benucci M, Saviola G, Baiardi P et al (2008) Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis. Clin Rheumatol 27:91–95. doi:10.​1007/​s10067-007-0728-5 CrossRefPubMed
30.
go back to reference Nardi N, Brito-Zerón P, Ramos-Casals M et al (2006) Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren’s syndrome, prevalence and clinical significance in 335 patients. Clin Rheumatol 25:341–346. doi:10.1007/s10067-005-0059-3 CrossRefPubMed Nardi N, Brito-Zerón P, Ramos-Casals M et al (2006) Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren’s syndrome, prevalence and clinical significance in 335 patients. Clin Rheumatol 25:341–346. doi:10.​1007/​s10067-005-0059-3 CrossRefPubMed
31.
go back to reference Rechlin M (1997) Systemic rheumatic diseases: undifferentiated connective tissue disease, overlap syndromes, and mixed connective tissue disease. In: Koopman WJ (ed) Arthritis and allied conditions a text book of rheumatology. William & Wilkins, Baltimore, pp 1445–1454 Rechlin M (1997) Systemic rheumatic diseases: undifferentiated connective tissue disease, overlap syndromes, and mixed connective tissue disease. In: Koopman WJ (ed) Arthritis and allied conditions a text book of rheumatology. William & Wilkins, Baltimore, pp 1445–1454
33.
go back to reference Jablonska S, Blaszczyk M (1999) Scleroderma overlap syndromes. Adv Exp Med Biol 455:85–92PubMed Jablonska S, Blaszczyk M (1999) Scleroderma overlap syndromes. Adv Exp Med Biol 455:85–92PubMed
34.
go back to reference Naiperi M, Karsunky H, Zevnik B et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181. doi:10.1038/76032 CrossRef Naiperi M, Karsunky H, Zevnik B et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181. doi:10.​1038/​76032 CrossRef
35.
Metadata
Title
DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren syndrome and healthy subjects
Authors
Salima Belguith-Maalej
Hassen Hadj-Kacem
Neila Kaddour
Zouhir Bahloul
Hammadi Ayadi
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0917-4

Other articles of this Issue 1/2009

Rheumatology International 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.